BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7711449)

  • 1. Rabies veterinary virus vaccine produced in BHK-21 cells grown on microcarriers in a bioreactor.
    Gallegos Gallegos RM; Espinosa Larios EL; Ramos Ramírez L; Kretschmer Schmid R; Aguilar Setién A
    Arch Med Res; 1995; 26(1):59-63. PubMed ID: 7711449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H; Rourou S; Majoul S; Loukil H
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economical production of rabies vaccine on cell cultures].
    Lalosević D; Lazarević-Ivanc L; Stankov S
    Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of YU BHK Rabivak vaccine against rabies in volunteers].
    Lalosević V; Lazarević-Ivanc L; Lalosević D
    Med Pregl; 2001; 54 Suppl 1():23-7. PubMed ID: 12078123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.
    Kallel H; Jouini A; Majoul S; Rourou S
    J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect in mice of the live rabies vaccine produced using the Göttingen bioreactor].
    Roth F; Ullrich MW
    Berl Munch Tierarztl Wochenschr; 1995 Dec; 108(12):471-5. PubMed ID: 8651900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of various immunochemical, biochemical and biological methods for the analysis of rabies virus production in tissue cultures.
    Adamovicz P; Aguilon F; David A; Le Fur R; Mazert MC; Perrin P; Reculard P; Sureau P
    Dev Biol Stand; 1983; 55():191-7. PubMed ID: 6677532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and replication of rabies virus in C6 rat glioma cells (clone CCL-107).
    Bordignon J; Piza AT; Alvarez-Silva M; Caporale GM; Carrieri ML; Kotait I; Zanetti CR
    Biologicals; 2001 Jun; 29(2):67-73. PubMed ID: 11580211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production.
    Mondal SK; Neelima M; Seetha Rama Reddy K; Ananda Rao K; Srinivasan VA
    Biologicals; 2005 Sep; 33(3):185-9. PubMed ID: 16084736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of influenza virus in serum-free mammalian cell cultures.
    Merten OW; Manuguerra JC; Hannoun C; van der Werf S
    Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
    Pay TW; Boge A; Menard FJ; Radlett PJ
    Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rabies vaccine produced in a non-tumorigenic rabbit cell line.
    Sureau P; Perrin P; Horaud F
    Dev Biol Stand; 1985; 60():133-9. PubMed ID: 4043531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications.
    Fontana D; Marsili F; Garay E; Battagliotti J; Etcheverrigaray M; Kratje R; Prieto C
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():70-75. PubMed ID: 31300130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
    Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW
    Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.